Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1819555
Max Phase: Preclinical
Molecular Formula: C41H69N13O11S2
Molecular Weight: 984.22
Molecule Type: Protein
Associated Items:
ID: ALA1819555
Max Phase: Preclinical
Molecular Formula: C41H69N13O11S2
Molecular Weight: 984.22
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C41H69N13O11S2/c1-3-21(2)33-40(64)49-24(11-12-30(44)55)36(60)51-27(17-31(45)56)37(61)52-28(20-67-66-19-23(43)34(58)50-26(38(62)53-33)16-22-8-5-4-6-9-22)41(65)54-15-7-10-29(54)39(63)48-25(13-14-42)35(59)47-18-32(46)57/h21-29,33H,3-20,42-43H2,1-2H3,(H2,44,55)(H2,45,56)(H2,46,57)(H,47,59)(H,48,63)(H,49,64)(H,50,58)(H,51,60)(H,52,61)(H,53,62)/t21-,23-,24-,25-,26-,27-,28-,29-,33-/m0/s1
Standard InChI Key: HVKIEOSRGWWEGS-VIZGXHJBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 984.22 | Molecular Weight (Monoisotopic): 983.4681 | AlogP: -4.28 | #Rotatable Bonds: 17 |
Polar Surface Area: 405.32 | Molecular Species: BASE | HBA: 15 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.37 | CX Basic pKa: 9.54 | CX LogP: -6.44 | CX LogD: -8.98 |
Aromatic Rings: 0 | Heavy Atoms: 67 | QED Weighted: 0.06 | Np Likeness Score: 0.33 |
1. Wisniewski K, Galyean R, Tariga H, Alagarsamy S, Croston G, Heitzmann J, Kohan A, Wisniewska H, Laporte R, Rivière PJ, Schteingart CD.. (2011) New, potent, selective, and short-acting peptidic V1a receptor agonists., 54 (13): [PMID:21688787] [10.1021/jm200278m] |
Source(1):